Brain tumor trial aims to boost radiation without extra harm
NCT ID NCT05871021
First seen Jan 11, 2026 · Last updated May 23, 2026 · Updated 22 times
Summary
This study tests a new approach for people with a fast-growing brain tumor called glioblastoma. Standard treatment uses radiation and chemo, but the tumor often comes back. Researchers are giving a higher radiation dose along with a drug called bevacizumab, which may protect healthy tissue. The goal is to improve survival without causing more side effects. About 146 adults aged 18 to 70 with a specific tumor type (IDH wild-type, MGMT unmethylated) can join.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOBLASTOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Department of Neurology, University Hospital Regensburg
RECRUITINGRegensburg, Germany
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Department of Radiation Oncology
RECRUITINGTübingen, 72076, Germany
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Department of Radiation Oncology, Medical Faculty Mannheim
RECRUITINGMannheim, Germany
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Department of Radiation Oncology, University Hospital Augsburg
RECRUITINGAugsburg, Germany
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Department of Radiation Oncology, University Hospital Frankfurt
RECRUITINGFrankfurt, Germany
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Department of Radiation Oncology, University Hospital Freiburg
RECRUITINGFreiburg im Breisgau, Germany
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Department of Radiation Oncology, University Hospital Köln
RECRUITINGCologne, Germany
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Department of Radiation Oncology, University Hospital Leipzig
RECRUITINGLeipzig, Germany
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Department of Radiation Oncology, University Hospital, LMU Munich
RECRUITINGMunich, Germany
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.